Thymalfasin from Chengdu Shengnuo Biopharm Co., Ltd.

Founded in 2004, Chengdu Shengnuo Biopharma is a leading Chinese manufacturer specializing in peptide and amino acid drugs. The company integrates R&D, production, and sales across four core areas: peptide APIs, CDMO services, cosmetic peptides, and peptide formulations.

Shengnuo operates 25 cGMP-compliant production lines, with an annual API production capacity exceeding 3 tons. Its manufacturing capabilities span five dosage forms, including injectables, lyophilized powders, and solid preparations. Several products are certified by major regulatory bodies such as the U.S. FDA, EU EDQM, South Korea MFDS, and Mexico Cofepris, and are exported to over 30 countries.

The company has developed commercial-scale production technologies for 50+ peptide drugs, with kilogram-scale...

Address: No. 258, Section 1,Gongye Avenue,Dayi County,, 611330, Chengdu
China
China Local time:

Dedicated to researching peptide drugs for over 20 years.

One-Stop CDMO Service Platform for Innovative Peptide Drugs

Covers the entire peptide industry chain

Our services:

APIs
CDMO

Response time:

Producer

Produced in:

China

MOQ: 1 g

  • GMP

  • CoA

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Chengdu Shengnuo Biopharm Co., Ltd. Thymalfasin API Producer - 62304-98-7

Description:
Chengdu Shengnuo Biopharm Co., Ltd. offers high-quality Thymalfasin API, certified for compliance with international standards. Manufactured in China. Dedicated to researching peptide drugs for over 20 years.. One-Stop CDMO Service Platform for Innovative Peptide Drugs. Covers the entire peptide industry chain.

Product Details

Certifications
GMP, CoA, MSDS, BSE/TSE compliant
Minimum Order Quantity
1 g
Produced in
China (Asia)
DrugBank ID
DB04900
CAS Number
62304-98-7
Unique Ingredient Identifier
W0B22ISQ1C
Raw Material Category
Immunostimulants

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 21 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Thymalfasin API? Contact Chengdu Shengnuo Biopharm Co., Ltd. by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Thymalfasin API

Chengdu Shengnuo Biopharm Co., Ltd.


Founded in 2004, Chengdu Shengnuo Biopharma is a leading Chinese manufacturer specializing in peptide and amino acid drugs. The company integrates R&D, production, and sales across four core areas: peptide APIs, CDMO services, cosmetic peptides, and peptide formulations.

Shengnuo operates 25 cGMP-compliant production lines, with an annual API production capacity exceeding 3 tons. Its manufacturing capabilities span five dosage forms, including injectables, lyophilized powders, and solid preparations. Several products are certified by major regulatory bodies such as the U.S. FDA, EU EDQM, South Korea MFDS, and Mexico Cofepris, and are exported to over 30 countries.

The company has developed commercial-scale production technologies for 50+ peptide drugs, with kilogram-scale single-batch API production. Core competencies include the industrial synthesis of thioether-cyclized and carbon-cyclized peptides, as well as rapid synthesis technologies for complex peptide structures.

Shengnuo owns 48 granted patents (33 invention, 13 utility model, 2 PCT), underscoring its innovation in peptide drug development. It operates four modern manufacturing sites, with API plants certified by China’s GMP and the U.S. FDA.

Shengnuo’s facilities are equipped with state-of-the-art instruments, including CS936 automated peptide synthesizers, Agilent LC-MS, and Waters UPLC systems—forming a globally advanced solid-phase peptide synthesis platform. Its large-scale peptide API production capacity ranks among the top in China.